CoChat

Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer‐like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein

Liskowsky, Wolfgang, Schliebs, Reinhard · 2006 · International Journal of Developmental Neuroscience
Cited by 73

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The molecular mechanisms of the interrelationship between cholinergic neurotransmission, processing of amyloid precursor protein (APP) and β‐amyloid (Aβ) production in vivo are still less understood. To reveal any effect of cholinergic dysfunction on APP processing in vivo, 11‐month‐old transgenic Tg2576 mice with Aβ plaque pathology received intraperitoneal injections of scopolamine at a daily dosage of 2 mg/kg body weight for 14 days in order to suppress cortical cholinergic transmission by chronic inhibition of muscarinic acetylcholine receptors. Scopolamine treatment of transgenic Tg2576 mice resulted in increased levels of fibrillar Aβ(1–40) and Aβ(1–42), while the soluble, SDS‐extractable Aβ level remained unchanged as compared to vehicle‐injected Tg2576 mice. α‐Secretase activity determined in cortical tissue from scopolamine‐treated Tg2576 mice was lower by about 30% as compared to that assayed in control mice, while β‐secretase activity and BACE1 protein expression appeared unaffected by scopolamine treatment. The amount of sAPPα, the product secreted by α‐secretase‐mediated APP cleavage, and the unprocessed APP were assayed in the soluble and membrane fraction, respectively, of cortical tissue preparations from treated and control mice by Western blotting. Using the anti antibody 6E10 which specifically labels human sAPPα and full length APP in transgenic Tg2576, an enhanced APP level was detected in the membrane fraction from treated mice as compared to controls, while in the soluble fraction scopolamine treatment did not affect the protein level of sAPPα. These data indicate an accumulation of APP in cortical membrane fraction in scopolamine‐treated Tg2576 mice presumably due to the decreased level of α‐secretase‐mediated APP cleavage, and further suggest that chronic suppresion of cortical muscarinic cholinergic transmission may alter the balance between α‐ and β‐secretory APP processing by favouring the amyloidogenic route.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijdevneu.2005.11.010

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 73

Metadata

Authors
Liskowsky, W., & Schliebs, R.
Venue
International Journal of Developmental Neuroscience
Publisher
Wiley
Published
2006-01-19
Volume
24
Issue
2-3
Pages
149-156
ISSN
  • 0736-5748 (ISSN-L)
  • 1873-474X
OpenAlex
W2028535639
Cited by
73
References
5
FWCI
2.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer‐like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein. https://app.cochat.ai/papers/10.1016/j.ijdevneu.2005.11.010
The paper
Liskowsky, W., & Schliebs, R. (2006). Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer‐like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein. International Journal of Developmental Neuroscience. https://doi.org/10.1016/j.ijdevneu.2005.11.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.